We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.11%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$354M
Cap. Flow
-$371M
Cap. Flow %
-3.39%
Top 10 Hldgs %
21.68%
Holding
2,365
New
95
Increased
251
Reduced
1,484
Closed
53

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$12.1M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$11.5M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$7.47M
4
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$6.8M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$5.09M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$65.3M
2
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$17.5M
3
PAA icon
Plains All American Pipeline
PAA
+$17.4M
4
AAPL icon
Apple
AAPL
+$15.4M
5
TRGP icon
Targa Resources
TRGP
+$13.5M

Sector Composition

Rank Sector Weight
1 Technology 20.23%
2 Financials 13.41%
3 Healthcare 12.54%
4 Consumer Discretionary 11.8%
5 Industrials 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XRN
1951
Chiron Real Estate Inc
XRN
$480M
$241K ﹤0.01%
3,680
+638
+21% +$42.4K
DHIL
1952
DELISTED
Diamond Hill
DHIL
$241K ﹤0.01%
1,546
– –
SPRY icon
1953
ARS Pharmaceuticals
SPRY
$601M
$241K ﹤0.01%
+5,527
New +$262K
IMVT icon
1954
Immunovant
IMVT
$8.8B
$241K ﹤0.01%
15,007
– –
CMTL icon
1955
Comtech Telecommunications
CMTL
$52.1M
$240K ﹤0.01%
9,651
-1,824
-16% -$46.4K
CARS icon
1956
Cars.com
CARS
$648M
$239K ﹤0.01%
18,448
-9,643
-34% -$126K
ARQT icon
1957
Arcutis Biotherapeutics
ARQT
$3.3B
$238K ﹤0.01%
8,244
– –
NKTX icon
1958
Nkarta
NKTX
$171M
$238K ﹤0.01%
7,243
– –
HVT icon
1959
Haverty Furniture Companies
HVT
$441M
$238K ﹤0.01%
6,403
– –
VOR icon
1960
Vor Biopharma
VOR
$1.32B
$238K ﹤0.01%
+276
New +$234K
RLMD icon
1961
Relmada Therapeutics
RLMD
$503M
$238K ﹤0.01%
6,754
– –
AUD
1962
DELISTED
Audacy, Inc.
AUD
$238K ﹤0.01%
+45,290
New +$220K
RIGL icon
1963
Rigel Pharmaceuticals
RIGL
$782M
$237K ﹤0.01%
6,933
+2,155
+45% +$85.3K
BY icon
1964
Byline Bancorp
BY
$1.78B
$236K ﹤0.01%
11,156
– –
ADVM
1965
DELISTED
Adverum Biotechnologies
ADVM
$236K ﹤0.01%
2,389
-1,373
-36% -$165K
PSNL icon
1966
Personalis
PSNL
$1.52B
$235K ﹤0.01%
9,566
– –
GOOD
1967
Gladstone Commercial Corp
GOOD
$630M
$235K ﹤0.01%
12,023
-6,147
-34% -$116K
FSP
1968
Franklin Street Properties
FSP
$46.3M
$235K ﹤0.01%
43,104
+17,319
+67% +$86.3K
BLFS icon
1969
BioLife Solutions
BLFS
$1.71B
$234K ﹤0.01%
6,501
– –
VRTV
1970
DELISTED
VERITIV CORPORATION
VRTV
$234K ﹤0.01%
+5,493
New +$158K
ATNI icon
1971
ATN International
ATNI
$478M
$234K ﹤0.01%
4,754
– –
MNRL
1972
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$233K ﹤0.01%
15,907
– –
ORIC icon
1973
Oric Pharmaceuticals
ORIC
$1.43B
$232K ﹤0.01%
9,451
– –
LDL
1974
DELISTED
Lydall, Inc.
LDL
$231K ﹤0.01%
6,860
-1,534
-18% -$52.5K
BFST icon
1975
Business First Bancshares
BFST
$1.05B
$231K ﹤0.01%
9,672
– –
77 78
79
80 81

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, MetLife Investment Management held 2,365 positions worth $10.9B, up 3.3% from $10.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management withdrew a net $371M in Q1 2021, closing 53 positions and reducing 1,484 holdings. Its most notable exit was Plains All American Pipeline, an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in NXP Semiconductors worth $13.3M.

  • MetLife Investment Management's largest Q1 2021 buy was NXP Semiconductors: 66,011 shares worth $13.3M.
  • MetLife Investment Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q1 2021, an estimated $11.5M increase.
  • MetLife Investment Management's biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $65.3M.
  • MetLife Investment Management fully exited Plains All American Pipeline in Q1 2021, selling an estimated $17.4M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $10.9B portfolio in Q1 2021.
  • MetLife Investment Management opened 95 new positions and closed 53 in Q1 2021.
  • MetLife Investment Management's portfolio value rose 3.3% quarter-over-quarter to $10.9B.

Based on MetLife Investment Management's 13F filing for Q1 2021, filed 14 May 2021.